Asia on the move: Five trends shaping the Asia biopharmaceutical market

May 14, 2018

Enthusiasm for the biopharmaceutical sector in Asia has been flat, due in part to China’s market-access blockade, Japan’s spending controls, and deceleration in India and Southeast Asia. Recent changes have reignited interest in the region, with important implications for pharma executives.

Read more...

Previous Article
Five Fifty: Try a little weird
Five Fifty: Try a little weird

Tony Hsieh, the unconventional CEO of Zappos, is not afraid to create “a little weirdness.” In fact it’s a ...

Next Article
Putting talent at the top of the CEO agenda
Putting talent at the top of the CEO agenda

McKinsey global managing partner Dominic Barton discusses how executives serious about delivering value nee...

Get the Latest People Performance & Human Capital Resources

Download